A multicenter study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine shows how interactions between tumor cells and immune components of the microenvironment can impact treatment responses and outcomes in patients newly diagnosed with multiple myeloma who undergo combination treatments that include targeted immunotherapy.
Researchers from Sylvester Comprehensive Cancer Center and Dana Farber Cancer Institute have received a $4 million five-year grant from NCI to determine whether lifestyle interventions, such as exercise and intermittent fasting, help patients with advanced breast cancer better tolerate side effects from treatment.
Stephen D. Nimer, director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, was named Researcher of the Year by BioFlorida, an association for the state’s life sciences industry.
Thoracic surgeons and researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine found that increasing numbers of patients undergoing cancer-removal lung surgery by “anatomic lung resections”—lobectomies or segmentectomies—are able to go home safely and without complications one day after the operation, thanks to growing rates of robot-assisted surgeries and improvements in patient-centered care protocols.
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are part of an international team of scientists who identified mechanisms by which some multiple myelomas become resistant to initially effective T-cell therapies.
Frank J. Penedo, associate director for cancer survivorship and translational behavioral sciences at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, is the recipient of the International Society of Behavioral Medicine’s 2023 ISBM Distinguished Scientist Award. The award was presented at the 17th Congress of the ISBM in Vancouver, British Columbia, and recognizes distinguished theoretical or empirical contributions to behavioral medicine.
Jashodeep Datta, a researcher with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has been awarded a grant from the U.S. Department of Defense’s Congressionally Directed Medical Research Program to target chemotherapy resistance in pancreatic cancer. The $800,000, three-year grant is the first DoD award to Sylvester to study pancreatic cancer.
Researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and Dana Farber Cancer Institute have received $7 million from the Patient-Centered Outcomes Research Institute to study how diet and exercise impact mental and physical functioning in older cancer survivors and their caregivers.
The Diversity in Cancer Research Internship Program, part of the University of Miami Miller School of Medicine, was established to give undergraduate college students from under-represented communities exposure and experience in the hopes of increasing diversity among cancer researchers.
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have developed an orally administered drug to disrupt prostate cancer cells’ metabolism and deliver the chemotherapy agent cisplatin directly into treatment-resistant prostate cancer cells.
